In patients with type 1 diabetes, hypoglycemia or degradation in blood glucose control may occur during and after physical exercise (13). This may be avoided in patients with good glycemic control by decreasing insulin doses and/or ingesting carbohydrate. Although most sport activities involve intense muscle exercise, current recommendations are based on studies on moderate exercise (4). We therefore investigated the effect of a drastic reduction in insulin dose before a 60-min high-intensity cycle exercise in 12 subjects with uncomplicated type 1 diabetes (age 32 ± 7 years, BMI 23 ± 7 kg/m2, HbA1c 7.2 ± 3.8%, and Vo2max 40 ± 27 ml · min−1 · kg−1 [mean ± SD]). Six patients were treated with three daily injections (regular insulin in the morning and at noon and mixed regular NPH insulin before dinner). The six remaining patients were treated with two daily injections (30% regular/70% NPH insulin). After determination of Vo2max, patients reported to the laboratory on two separate occasions, 1 week apart, in randomized order 90 min after breakfast (60 g carbohydrates, 10 g lipids, and 8 g proteins) to perform a 60-min exercise session on an ergocycle at 70% Vo2max. On one occasion, exercise was performed with the usual morning insulin dose. On the other, morning insulin dose was reduced by 90% for patients treated with three daily injections and by 50% for patients treated with two injections per day. Power output was monitored and strictly maintained during the tests to correspond to ∼70% Vo2max.

Changes in plasma glucose (PG) levels were analyzed by a mixed-model ANCOVA, with a random subject effect and random coefficients for time within each subject, using the SAS version 6.12 software package (SAS Institute, Cary, NC).

At the beginning of exercise and over the test period, PG levels were higher in the experimental condition with insulin dose reduction (P < 0.0001) (Fig. 1). Changes in PG levels were similar in both conditions during exercise and recovery (P = 0.99). No difference was observed when considering insulin regimen. During exercise, the mean decrease in PG concentrations was −0.085 ± 0.012 mmol · l−1 · min−1 (mean ± SE) (P < 0.0001), whereas no significant variation was observed during the recovery period. When exercise was performed without reducing insulin doses, eight patients (66%) had hypoglycemia and were given oral sucrose (22 ± 3 g). Changes in plasma lactate, growth hormone, cortisol, glucagon, and norepinephrine were not statistically different. The peak of plasma epinephrine concentration was higher in the test without insulin reduction: 2.3 ± 1.5 vs. 1.1 ± 0.7 nmol/l (P < 0.04, Student’s t test).

In previous studies, decreasing insulin dose before moderate exercise (∼55% Vo2max) was not associated with degradation in blood glucose control during and after exercise (1,4,5). However, most sport activities, whether individual (running, biking, hiking, and swimming) or team (basketball, football, and handball) involve intense muscle exercise. We show here that a 90% reduction of morning regular insulin before intense exercise allows the maintenance of near normal blood glucose levels without occurrence of hypoglycemia. When insulin was not reduced, two-thirds of patients experienced hypoglycemia.

This study emphasizes the importance of insulin-independent contraction-induced glucose uptake by muscle, previously demonstrated in healthy men (6) and mice lacking muscle insulin receptor (rev. in 7).

In conclusion, we demonstrate that type 1 diabetic patients can perform intense muscle exercise after a 50–90% reduction in insulin dose, depending on their insulin regimen. This decrease prevents hypoglycemia without worsening metabolic control. Such advice could be given to young type 1 diabetic patients engaged in sports activities.

Figure 1—

Changes in PG levels during exercise and recovery performed with (▪) and without (□) insulin reduction. Of 12 patients, 8 received oral glucose during the condition without insulin reduction. Data are expressed as mean ± SE (n = 12).

Figure 1—

Changes in PG levels during exercise and recovery performed with (▪) and without (□) insulin reduction. Of 12 patients, 8 received oral glucose during the condition without insulin reduction. Data are expressed as mean ± SE (n = 12).

Close modal
1
Berger M, Berchtold P, Cuppers HJ, Drost H, Kley HK, Muller WA, Wiegelmann W, Zimmerman-Telschow H, Gries FA, Kruskemper HL, Zimmermann H: Metabolic and hormonal effects of muscular exercise in juvenile type diabetics.
Diabetologia
13
:
355
–365,
1977
2
Koivisto VA, Felig P: Effects of leg exercise on insulin absorption in diabetic patients.
N Engl J Med
298
:
79
–83,
1978
3
Horton ES: Role and management of exercise in diabetes mellitus.
Diabetes Care
11
:
201
–211,
1988
4
Schiffrin A, Parikh S: Accommodating planned exercise in type I diabetic patients on intensive treatment.
Diabetes Care
8
337
–342,
1985
5
Schmulling RM, Jakober B, Pfohl M, Overkamp D, Eggstein M: Exercise and insulin requirements.
Horm Metab Res Suppl
24
:
83
–87,
1990
6
Wasserman DH, Geer RJ, Rice DE, Bracy D, Flakoll PJ, Brown LL, Hill JO, Abumrad NN: Interaction of exercise and insulin action in humans.
Am J Physiol
260
:
E37
–E45,
1991
7
Mauvais-Jarvis F, Kulkarni RN, Kahn CR: Knockout models are useful tools to dissect the pathophysiology and genetics of insulin resistance.
Clin Endocrinol (Oxf)
57
:
1
–9,
2002

Address correspondence to Dr. Jean-François Gautier, Department of Endocrinology and Diabetes, Saint-Louis Hospital, 1, Avenue Claude Vellefaux, 75010 Paris, France. E-mail: [email protected].